Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
J., & Ho, K
The rate of treatment discontinuation due to adverse events was comparable to what has been observed in trials of GLP-1 monotherapy
Stop and Seek Help If Any signs of allergic reactionstop immediately and get medical help Persistent metallic taste that doesn't go away (possible copper excess) Injection site reactions that spread, worsen, or show signs of infection Nausea or stomach upset that persists beyond the first few days Unusual skin discoloration away from injection sites Your treatment goals have been achieved and you're in maintenance mode GHK-Cu is a research compound, not an FDA-approved medication
A common approach goes something like: gather some data, start your intervention, measure again, and repeat until you are satisfied that something is working or isnt
#pharmd To view or add a comment, sign in Weight-loss drug reduces heart risks The weight-loss drug semaglutide, found in Wegovy and Ozempic, cuts the risk of cardiovascular problems such as heart attack or stroke, regardless of how much weight people lose, according to a new study published in the Lancet
